{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:33:24Z","timestamp":1775025204197,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T00:00:00Z","timestamp":1529971200000},"content-version":"vor","delay-in-days":390,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jcin.2017.03.029","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T11:00:21Z","timestamp":1497956421000},"page":"1222-1229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Long-Term Clinical Outcomes of Patients\u00a0Treated With Everolimus-Eluting Bioresorbable Stents in Routine Practice"],"prefix":"10.1016","volume":"10","author":[{"given":"Jens","family":"Wiebe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Hoppmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roisin","family":"Colleran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Kufner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Valeskini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Cassese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Joner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heribert","family":"Schunkert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-Ludwig","family":"Laugwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Kastrati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2017.03.029_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.03.029_bib2","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1016\/j.jacc.2014.09.041","article-title":"Current status of bioresorbable scaffolds in the treatment of coronary artery disease","volume":"64","author":"Wiebe","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.03.029_bib3","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/S0140-6736(16)32050-5","article-title":"Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial","volume":"388","author":"Serruys","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2017.03.029_bib4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(15)00979-4","article-title":"Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials","volume":"387","author":"Cassese","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2017.03.029_bib5","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jacc.2015.11.060","article-title":"A\u00a0polylactide bioresorbable scaffold eluting everolimus for treatment of coronary stenosis: 5-year follow-up","volume":"67","author":"Serruys","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.03.029_bib6","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.4244\/EIJY16M09_01","article-title":"Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial","volume":"12","author":"Onuma","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2017.03.029_bib7","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.4244\/EIJY16M08_01","article-title":"Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial","volume":"12","author":"Chevalier","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2017.03.029_bib8","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.4244\/EIJY14M07_11","article-title":"Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry","volume":"10","author":"Capodanno","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2017.03.029_bib9","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.4244\/EIJV12I2A28","article-title":"One-year outcomes after Absorb bioresorbable vascular scaffold implantation in routine clinical practice","volume":"12","author":"Capranzano","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2017.03.029_bib10","first-page":"316","article-title":"Twelve-month outcomes with a bioresorbable everolimus-eluting scaffold: results of the ESHC-BVS registry at two Australian centers","volume":"28","author":"Robaei","year":"2016","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.jcin.2017.03.029_bib11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4244\/EIJY14M12_10","article-title":"Beyond the early stages: insights from the ASSURE registry on bioresorbable vascular scaffolds","volume":"11","author":"Wohrle","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2017.03.029_bib12","first-page":"822","article-title":"Angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine clinical practice: results of the ISAR-ABSORB registry","volume":"87","author":"Hoppmann","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2017.03.029_bib13","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"issue":"Suppl V","key":"10.1016\/j.jcin.2017.03.029_bib14","doi-asserted-by":"crossref","first-page":"V159","DOI":"10.4244\/EIJV11SVA39","article-title":"Pathological aspects of bioresorbable stent implantation","volume":"11","author":"Sanchez","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2017.03.029_bib15","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCINTERVENTIONS.112.971549","article-title":"First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study","volume":"5","author":"Ormiston","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2017.03.029_bib16","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/eurheartj\/ehr466","volume":"33","author":"Brugaletta","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2017.03.029_bib17","series-title":"Everolimus-eluting bioresorbable vascular scaffolds in patients with coronary artery disease: ABSORB III trial 2-year results. Presented at: American College of Cardiology","author":"Ellis","year":"2017"},{"key":"10.1016\/j.jcin.2017.03.029_bib18","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1614954","article-title":"Bioresorbable scaffolds versus metallic stents in routine PCI","author":"Wykrzykowska","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2017.03.029_bib19","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ahj.2012.08.010","volume":"164","author":"Diletti","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2017.03.029_bib20","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1093\/eurheartj\/ehv435","article-title":"A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan","volume":"36","author":"Kimura","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2017.03.029_bib21","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.4244\/EIJY16M05_03","article-title":"Impact of stent size on angiographic and clinical outcomes after implantation of everolimus-eluting bioresorbable scaffolds in daily practice: insights from the ISAR-ABSORB registry","volume":"12","author":"Wiebe","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2017.03.029_bib22","unstructured":"Kereiakes DJ, Ellis SG, Metzger DC, et\u00a0al. Everolimus-eluting bioresorbable vascular scaffolds in patients with coronary artery disease: the ABSORB III trial. Presented at: Transcatheter Cardiovascular Therapeutics meeting (TCT 2015); October 12, 2015, San Francisco, CA."},{"key":"10.1016\/j.jcin.2017.03.029_bib23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.carrev.2015.09.003","article-title":"Impact\u00a0of the learning curve on procedural results and acute outcome after percutaneous coronary interventions with everolimus-eluting bioresorbable scaffolds in an all-comers population","volume":"16","author":"Wiebe","year":"2015","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jcin.2017.03.029_bib24","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jacc.2015.12.019","article-title":"Bioresorbable coronary scaffold thrombosis: multicenter comprehensive analysis of clinical presentation, mechanisms, and predictors","volume":"67","author":"Puricel","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.03.029_bib25","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.4244\/EIJ-D-16-00974","article-title":"Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score","volume":"12","author":"Ortega-Paz","year":"2017","journal-title":"EuroIntervention"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879817306441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879817306441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:05:29Z","timestamp":1761847529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879817306441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1936879817306441"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2017.03.029","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Clinical Outcomes of Patients\u00a0Treated With Everolimus-Eluting Bioresorbable Stents in Routine Practice","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2017.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}